| Popis: |
Background: The purpose of the study was to investigate the impact of epidural analgesia usage vs. non-epidural labor on maternal and neonatal outcomes. Methods: We included 129 parturients who had vaginal deliveries in our hospital since December 1, 2018. The women were grouped into the epidural analgesia group or the non-epidural group. In order to investigate the effect of epidural analgesia on mother and newborn outcomes, we evaluated the differences in labor duration, the Apgar score of the newborn, and the overall outcome of the mother and newborn. Results: Compared to the non-epidural group, the durations of the first and second stages of labor in the analgesia group were significantly longer. In terms of neonatal outcome, the epidural analgesia group had a higher lactate value in the umbilical artery blood and higher pCO2 of umbilical vein blood of the neonates. However, there were no significant differences in Apgar Score, umbilical blood pH, base excess, or other umbilical cord blood gas analyses (pO2, HGB, SO2, HCO3 -) between epidural analgesia and non-epidural labor groups.Conclusion: The epidural analgesia prolongs the duration of the first and second stages of labor and affects the level of lactate in umbilical artery blood and the partial pressure of carbon dioxide in umbilical vein blood. There was no significant effect on the basic characteristics of the mothers and neonates, suggesting that epidural analgesia delivery technology is safe, but it may have a particular short-term impact on neonatal outcomes. |
